Case Report
Copyright ©The Author(s) 2024.
World J Clin Cases. Jul 16, 2024; 12(20): 4427-4433
Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4427
Table 2 Clinical data summary for each benign recurrent intrahepatic cholestasis episode
Attack
Date
Total bilirubin max (μmol/L)
ALP max
(U/L)
GGT (U/L)
Treatment
Duration
1October, 201993.1265NormalUDCA, diammonium glycyrrhizinate8 wk
2April, 202064.5156NormalUDCA, diammonium glycyrrhizinate6 wk
3August, 2020279.0151NormalUDCA, antihistamines, rifampicin, 11 wk
4March, 202188.7166NormalUDCA6 wk